Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.39
+2.1%
$0.46
$0.19
$0.90
$9.63M1.1136,035 shs42,903 shs
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$0.76
+4.4%
$0.66
$0.40
$1.39
$36.04M0.66189,577 shs344,609 shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.80
+0.8%
$3.23
$2.30
$4.42
$38.42M1.32138,532 shs182,473 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.37
-0.3%
$0.29
$0.03
$1.00
$42.20M1.2674,785 shs12,214 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biotricity, Inc. stock logo
BTCY
Biotricity
+2.14%-5.48%-19.46%-7.95%-56.62%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
+4.42%+0.80%+16.25%+30.26%-13.86%
PolyPid Ltd. stock logo
PYPD
PolyPid
+0.80%+9.51%+7.65%+38.64%+8.26%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
+11.82%+19.59%+43.08%+3.50%+900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/AN/AN/AN/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
2.6097 of 5 stars
3.55.00.00.02.20.80.0
PolyPid Ltd. stock logo
PYPD
PolyPid
2.997 of 5 stars
3.65.00.00.02.41.70.0
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
3.00
Buy$1.4591.93% Upside
PolyPid Ltd. stock logo
PYPD
PolyPid
3.17
Buy$11.80210.53% Upside
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BTCY, NMTC, PYPD, and TMDIF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$12.00 ➝ $9.00
6/17/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$16.00 ➝ $14.00
6/9/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $13.00
6/5/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$9.00
6/2/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$11.00
5/5/2025
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$1.45
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M0.80N/AN/A($1.30) per share-0.30
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$3.45M10.91N/AN/A$0.03 per share25.18
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/A$0.75 per shareN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$17.63M2.39$18.50 per share0.02$1.05 per share0.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$1.08N/AN/A-80.42%N/A-188.47%8/18/2025 (Estimated)
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$12.32M-$0.22N/AN/A-75.41%-334.64%-124.42%8/13/2025 (Estimated)
PolyPid Ltd. stock logo
PYPD
PolyPid
-$29.02M-$4.30N/AN/AN/A-1,069.37%-151.85%8/13/2025 (Estimated)
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$6.95M$0.05N/AN/AN/A-82.31%-51.47%N/A

Latest BTCY, NMTC, PYPD, and TMDIF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.53N/AN/AN/AN/AN/A
5/14/2025Q1 2025
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.80-$0.70+$0.10-$0.70N/AN/A
5/13/2025Q2 2025
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$0.09-$0.07+$0.02-$0.07$1.27 billion$1.39 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/AN/AN/AN/AN/A
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/A
2.13
1.09
PolyPid Ltd. stock logo
PYPD
PolyPid
4.43
0.71
0.71
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/A
3.73
3.73

Institutional Ownership

CompanyInstitutional Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
16.07%
PolyPid Ltd. stock logo
PYPD
PolyPid
26.47%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.03%

Insider Ownership

CompanyInsider Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
8.90%
PolyPid Ltd. stock logo
PYPD
PolyPid
24.70%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.02%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4024.91 million22.08 millionOptionable
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
2049.82 million45.38 millionOptionable
PolyPid Ltd. stock logo
PYPD
PolyPid
8010.19 million7.67 millionNo Data
Titan Medical Inc. stock logo
TMDIF
Titan Medical
50114.04 million4.56 millionNot Optionable

Recent News About These Companies

Titan Announces Resignations of Directors
Proxy Deadline Thursday September 26, 2024
Titan Announces Q&A Session with Shareholders
Titan Medical | Morning Blend
Titan Medical Inc. (QTNA.SG)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.39 +0.01 (+2.14%)
As of 07/17/2025 03:58 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

NeuroOne Medical Technologies stock logo

NeuroOne Medical Technologies NASDAQ:NMTC

$0.76 +0.03 (+4.42%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$0.77 +0.01 (+1.92%)
As of 07/17/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

PolyPid stock logo

PolyPid NASDAQ:PYPD

$3.80 +0.03 (+0.80%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$3.69 -0.11 (-2.87%)
As of 07/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Titan Medical stock logo

Titan Medical NASDAQ:TMDIF

$0.37 0.00 (-0.27%)
As of 07/16/2025

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.